"Neumora’s Alzheimer’s disease agitation drug shows early success in Phase Ib trial" was originally created and published by ...

High levels of calcium are toxic to cells and contribute to loss of neurons in Alzheimer’s disease. A new JCI Insight study ...

Most often, caregivers are “told” what they should or could be doing in the care of their loved ones with Alzheimer’s disease ...

I inherited $400,000 and I have absolutely no idea what to do. I’m retired and 72. I’ve been diagnosed with Alzheimer’s ...

One of the biggest challenges in treating Alzheimer's disease (AD) is how heterogeneous it is in terms of speed of decline ...

Alzheimer’s may advance by breaking the brain’s internal clock—and resetting it could help fight the disease. Alzheimer’s disease often interferes with a person’s normal daily patterns. Early warning ...

A recent study by the Laboratory for Neuro-Analysis and Imaging (LANAI) at UMass Chan Medical School highlights how ...

Researchers discovered that clogged brain “drains” show up early in people at risk of Alzheimer’s disease. These blockages, ...

By Dennis Thompson HealthDay ReporterTUESDAY, Jan. 6, 2026 (HealthDay News) — A mail-in blood test accurately detects markers ...

Alzheimer’s disease affects millions worldwide—but confirming a diagnosis is far from simple. Doctors currently rely on ...

Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's ...

Summary: Researchers have created a new experimental model that reveals how changing a key Alzheimer’s risk gene can shift ...